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Background: Direct-to-consumer (DTC) prescription drug advertisements are thought
to induce “boomerang effects,” meaning they reduce the perceived effectiveness of
a potential alternative option: non-pharmaceutical treatment via lifestyle change. Past
research has observed such effects using artificially created, text-only advertisements
that may not adequate capture the complex, conflicting portrayal of lifestyle change in
real television advertisements. In other risk domains, individual “problem status” often
moderates boomerang effects, such that subjects who currently engage in the risky
behavior exhibit the strongest boomerang effects.
Objectives: We aimed to assess whether priming with real DTC television
advertisements elicited boomerang effects on perceptions of lifestyle change and
whether these effects, if present, were moderated by individual problem status.
Methods: We assembled a sample of real, previously aired DTC television
advertisements in order to naturalistically capture the portrayal of lifestyle change in real
advertisements. We randomized 819 adults in the United States recruited via Amazon
Mechanical Turk to view or not view an advertisement for a prescription drug. We further
randomized subjects to judge either lifestyle change or drugs on three measures: general
effectiveness, disease severity for a hypothetical patient, and personal intention to use
the intervention if diagnosed with the target health condition.
Results: Advertisement exposure induced a statistically significant, but weak,
boomerang effect on general effectiveness (p = 0.01, partial R2 = 0.007) and did not
affect disease severity score (p = 0.32, partial R2 = 0.0009). Advertisement exposure
elicited a reverse boomerang effect of similar effect size on personal intentions, such
that advertisement-exposed subjects reported comparatively higher intentions to use
lifestyle change relative to drugs (p = 0.006, partial R2 = 0.008). Individual problem
status did not significantly moderate these effects.
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Conclusion: In contrast to previous literature finding large boomerang effects using
artificial advertisement stimuli, real television advertisements elicited only a weak
boomerang effect on perceived effectiveness and elicited an unexpected reverse
boomerang effect on personal intentions to use lifestyle change versus drugs. These
findings may reflect real advertisements’ induction of descriptive norms and self-
efficacy; future research could address such possibilities by systematically manipulating
advertisement content.
Keywords: direct-to-consumer advertising, risk compensation, health psychology, boomerang effect, attitude
change
INTRODUCTION
Direct-to-consumer (DTC) advertising of prescription drugs
is a flourishing industry. Pharmaceutical companies spent an
estimated $4.5 billion on DTC promotion in the United States
in 2009 (Mackey et al., 2015). However, there is longstanding
debate over whether US federal law should more stringently
regulate DTC advertising or even prohibit it entirely, as is
currently the case in all countries except the US, New Zealand,
and Brazil. In particular, the issue of how these advertising
campaigns could shift lay consumer perceptions and health
behavior has attracted a flurry of controversy (Wilkes et al.,
2000; Hollon, 2005; Adams and Gables, 2016): DTC drug
advertisements might beneficially raise health awareness among
lay consumers (Dubois, 2003) or, alternatively, might encourage
overtreatment, overprescription, and inappropriate use (Hollon,
2005).
Epidemiological research on the effect of DTC advertising
on behavioral and economic outcomes has yielded mixed
results. Patients were more likely to request a DTC-advertised
drug in Sacramento, CA, where DTC advertising is legal,
than in Vancouver, Canada, where DTC advertising is illegal
(Mintzes et al., 2003). Additionally, patients with higher self-
reported exposure to advertising requested more advertised
drugs (Mintzes et al., 2003). The most heavily DTC-advertised
drugs in 1999 saw the highest 1-year growth in sales (Findlay,
2001). However, monthly expenditures on DTC advertising are
positively associated with physician diagnoses and prescriptions
only for certain drugs and pharmaceutical classes, with other
drugs and classes showing no association or a negative association
(Calfee et al., 2002; Zachry et al., 2002). Specifically regarding
lifestyle choices, DTC television advertising for statin drugs from
2001 to 2009 was associated cross-sectionally with increases in
visits to fast-food restaurants, but also with increased exercise
frequency (Niederdeppe et al., 2016).
From a cognitive perspective, increases in the frequency of
DTC advertising on television in the US from 2001 to 2007 were
cross-sectionally associated with increases in guilt surrounding
failure to engage in healthy lifestyle behaviors (Kruger et al.,
2015), which could usefully catalyze behavior change or reflect a
detrimental reduction in self-efficacy, an important component
of successful behavior change (Ajzen, 1991). Interpretation of
these mixed findings is further complicated by the usual caveats of
observational research and the fact that advertising expenditure
clearly is not determined in isolation, but rather is responsively
adjusted to market conditions and sales figures (Dulisse, 1997).
Internal marketing research on DTC advertising conducted by
pharmaceutical companies is not publicly available.
Given that the primary objective of DTC advertising is to
increase pharmaceutical sales, a point of particular concern is
how these advertisements could affect lay perceptions of non-
pharmaceutical lifestyle change to treat and prevent disease.
Exposure to messages promoting risk-reducing remedies can
decrease risk perceptions and increase risky behavior (termed
the “boomerang effect” or “risk compensation”). Such effects
have been demonstrated in randomized experiments in diverse
risk domains, including smoking, irresponsible credit card usage,
fat consumption, and behaviors promoting online identity theft
(Bolton et al., 2006). Paradoxically, individuals who currently
engage in target risky behaviors (those with high “problem
status”) are often most prone to boomerang effects. A study
using an artificially created, text-only advertisement for a
cholesterol-lowering drug demonstrated boomerang effects on
perceptions of the effectiveness of lifestyle change, and the effect
was moderated by individual problem status (Bolton et al.,
2008).
The portrayal of lifestyle change in actual DTC television
advertising is complex. A content analysis of 38 television
advertisements found that a high proportion (18.4%) portrayed
lifestyle changes as insufficient for controlling the target health
condition, and not a single advertisement described lifestyle
as an alternative to drugs (Frosch et al., 2007). On the other
hand, 53% of advertisements portrayed the protagonist engaging
in physical activity, which might promote a positive view
of lifestyle change by fostering descriptive norms for a high
prevalence of healthy lifestyle behaviors. Descriptive norms are
an individual’s perception of the extent to which others engage
in a target behavior, and they are an important predictor of both
health-promoting and health-detrimental behaviors (Webb and
Sheeran, 2006). An experimentally constructed social network
demonstrated striking causal effects of peers’ health-related
behaviors on subsequent individual behavior change (Centola,
2010). Quasi-experimental and observational evidence using
naturalistic social networks similarly showed that individual
development of obesity (Christakis and Fowler, 2007) and use
of alcohol (Kremer and Levy, 2008) are associated with the
individual’s proximity to peers who demonstrate these behaviors.
Together, these findings on descriptive norms and peer effects
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suggest mechanisms by which portrayals of healthy lifestyles in
DTC advertising could, in theory, improve perceptions of lifestyle
change.
However, DTC advertising does not paint a uniformly
positive picture of lifestyle change: a census study of television
advertisements for cholesterol-lowering drugs found that many
(73%) made explicit claims about the efficacy or inefficacy of
diet or exercise, with most of these cases (65%) sending mixed
messages via statements such as, “Diet and exercise are important,
but when they aren’t enough. . .” The frequent and conflicting
portrayal of lifestyle change in actual DTC television advertising
stands in contrast to portrayals in the simple advertisement
stimuli previously shown to demonstrate boomerang effects. For
example, these advertisement stimuli did not in any way mention
lifestyle change. Additionally, randomized past research has
typically used printed advertisements; the comparatively richer
multimedia content and length of television advertisements
suggests they might contain more complex portrayals of lifestyle
change than their printed counterparts. Thus, assessing the
existence of boomerang effects in a sample of real DTC television
advertisements is an important step toward understanding their
public health implications.
In light of the limitations of previous research, we performed
a high-powered randomized experiment to directly assess
possible boomerang effects of DTC advertising on judgments
of lifestyle change and drugs. We experimentally manipulated
exposure to one of six real DTC television advertisements
for three health conditions (high cholesterol, diabetes, and
depression) and examined the effect of advertisement exposure
on laypeople’s estimates of effectiveness and personal intentions
to use lifestyle change versus drugs to alleviate the target
health condition. Because our aim was to assess the effect of
exposure to real advertisements rather than to specific elements
of content, we assembled a sample of advertisement stimuli
representing a variety of health conditions and major drug
brands rather than selecting advertisements for predetermined
characteristics or for particular references to lifestyle. To
maximize external validity, stimuli were actual, previously aired
advertisements.
MATERIALS AND METHODS
Design Overview
This study was approved by the Stanford University IRB,
and the requirement for written consent was waived. We
randomized subjects using a three-factor (health condition X
advertisement exposure X judgment of lifestyle change versus
drugs) between-subjects design (Figure 1). Randomization was
conducted internally via an online questionnaire design software
(2013, Qualtrics, Provo, UT, USA) and was balanced across the
18 experimental conditions.
At the beginning of the questionnaire, subjects either viewed
a drug advertisement for the target health condition (Table 1)
and completed an attention-check question, or in the no-
advertisement conditions, proceeded directly to the effectiveness
questions. (Because of the inherent difficulty of identifying a truly
“neutral” counterpart to the advertisement stimuli, particularly
with regard to norm induction, we did not present any video
clip to subjects in no-advertisement conditions.) Advertisements
were viewed once. Then, each subject judged the effectiveness of
either lifestyle change or prescription drugs for the target health
condition. The between-subjects manipulation of intervention
type eliminated the possibility that subjects would experience
order effects or directly compare the two types of interventions.
We tested all questionnaire materials for comprehension on pilot
samples and, in the experimental sample, probed for confusion
or technical problems.
Setting and Participants
We sampled 819 subjects via Amazon Mechanical Turk, a
crowdsourcing platform allowing workers to complete brief
online tasks in exchange for pay. By contractual agreement
with Mechanical Turk, workers must be at least 18 years of
age. Workers tend to be somewhat younger, more educated,
and lower-income than the US general population, but are
demographically more representative than typical university-
based research samples (Paolacci et al., 2010). Studies performed
on Mechanical Turk yield high-quality data, minimize
experimental biases, and successfully replicate the results of
behavioral studies performed on traditional samples (Paolacci
et al., 2010). Given the nearly ubiquitous reach of DTC
advertising in the US, its public health implications may extend
far beyond patients with the targeted health conditions; we
therefore did not restrict the sample to individuals with specific
health conditions. The task title and description were vague
to minimize sampling bias and demand characteristics. We
sampled US workers with excellent performance history (>95%
of previous online tasks “approved” as high-quality by requester)
and compensated each subject $0.25.
Advertisement Stimuli
We selected three target health conditions (high cholesterol,
diabetes, and depression) that are widespread, familiar to
laypeople, and at least somewhat responsive to lifestyle
change, specifically of dietary or exercise habits (Gillies
et al., 2007; Thomas and Elliott, 2009; Hooper et al.,
2012; Rimer et al., 2012). For each of these three health
conditions, we obtained approximately 1-min advertisements
for two major brands, for a total of six advertisements
(Table 1). We obtained them from an online pharmaceutical
advertising database1, manufacturer websites, and YouTube.com.
All advertisements had aired since 2008 on United States
television networks.
Attention Check
For subjects who viewed an advertisement, we included the
multiple-choice attention check question “According to the
video, what is the purpose of the drug?”, to which only one of
seven possible answers was correct. We eliminated from analysis
all subjects responding incorrectly to this question (an a priori
decision).
1http://AdPharm.net
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FIGURE 1 | Experimental conditions and sample sizes. Values in the final column represent the number of subjects in that condition in the final, analyzed
sample.
TABLE 1 | Content of Advertisement Stimuli
Brand, year aired,
generic name
Plot Explicit references to lifestyle Duration
(min:sec)
High cholesterol
Crestor (2013)
Rosuvastatin calcium
Man eagerly watching television sees an ad for Crestor
and celebrates. His room is full of sports-like
memorabilia bearing Crestor’s name and logo colors.
None 1:00
Lipitor (2012)
Atorvastatin calcium
Cyclist compares “steep risks” he took as teenager to
risk of not taking Lipitor for high cholesterol. Vignettes
of protagonist tossing football with son, riding bicycle,
going to amusement park with family.
Protagonist states, “Why kid myself? Diet and
exercise weren’t lowering my cholesterol
enough. Now I’m eating healthier, exercising
more, taking Lipitor.”
1:00
Diabetes
Levemir FlexPen (2013)
Insulin detemir
Woman describes the changes she must make after
having been diagnosed with diabetes. Doctor hands her
advertised product. Woman drives with family to attend
grandmother’s birthday party, poses for family photo.
Protagonist states, “There’s a lot I have to do:
check my blood sugar, eat better, start insulin.”
1:15
Januvia (2008)
Sitagliptin
Vignettes of woman repeatedly climbing stairs, couple
preparing vegetables, and woman walking through the
park.
The message “Today I chose to take the stairs”
appears onscreen.
0:53
Depression
Abilify (2014)
Aripiprazole
Animated woman “feels stuck” and “still struggles” with
depression despite taking an antidepressant, a tablet of
which follows her throughout the ad. She consults her
doctor, who recommends adding Abilify. Protagonist is
shown smiling at a work meeting and interacting with
family.
None 1:31
Latuda (2014)
Lurasidone HCl
Vignettes of woman brushing her hair, riding bike,
speaking to doctor, watching children at playground,
going to work, having lunch with friend, walking dog,
and walking on beach with family.
None 1:31
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Outcome Measures
We collected both direct and indirect outcome measures,
comprising two measures of perceived effectiveness and one
measure of personal intention to use either lifestyle change or
drugs (Weinstein, 1998).
To measure perceived general effectiveness, we asked, “In
your opinion, how effective is/are [intervention] at helping with
[health condition]?”, where words in brackets depended on the
subject’s experimental group. Lifestyle change was described
as “healthy lifestyle changes (such as improving nutrition,
controlling weight, and increasing exercise),” corresponding to
recommendations published by the Centers for Disease Control
and Prevention [CDC] (Singer, 2009; Centers for Disease
Control and Prevention, 2013). Drugs were described as “[health
condition] drugs.” Subjects responded on an integer-valued, 100-
point visual analog scale (VAS) with four evenly-spaced verbal
labels: “Very Ineffective,” “Ineffective,” “Effective,” and “Very
Effective” on which higher values indicated higher effectiveness.
For the second outcome measure, disease severity score,
subjects read instructions explaining that the lower the score, the
better. They were instructed to “Imagine a patient with [health
condition] (score 161) who begins using [intervention]. Please
estimate the patient’s [health condition] score after 6 months of
using [intervention].” Subjects responded on a 180-point VAS.
For the intention outcome, we asked, “Imagine you were
recently diagnosed with [health condition]. How likely would you
be to use [intervention]?” Subjects responded on a VAS identical
to that used for the general effectiveness measure.
Problem Status
We operationalized individual problem status via two questions
gaging current adherence to exercise and diet recommendations:
“Do you currently engage in at least: 75 min per week of
vigorous-intensity physical exercise, OR 150 min of moderate-
intensity exercise?” and “On a typical day, do you eat a healthy
diet (rich in vegetables, limited in refined sugar, limited in
fatty and fried foods, low in highly processed junk food)?”
Subjects currently meeting criteria for both exercise and a
healthy diet were classified as “low problem status,” while subjects
failing to meet either criterion were classified as “high problem
status.”
Chronic Television Exposure
Previous observational research has documented an association
between chronic exposure to advertising and prescription
drug requests (Mintzes et al., 2003). As a proxy, we
measured chronic television exposure with the question:
“On a typical day, how many hours of television do you
watch?”
Demographic and Behavioral Measures
We collected data on the following demographic and behavioral
characteristics: age, sex, body mass index (BMI) (calculated from
height and weight), diet, exercise, education level, number of
prescription drugs taken regularly, and duration of television
watched on a typical day. These factual questions appeared at the
end of the survey to prevent priming and stereotype threat effects
on the outcome measures (Steele and Aronson, 1995; Burgess
et al., 2010).
Statistical Analysis
We performed all analyses in R (Version 3.0.2, multiple
contributors, Vienna, Austria) (Fox and Weisberg, 2010; R Core
Development Team, 2014) and defined statistical significance at
an alpha level of 0.05. All tests were two-sided.
Primary Analyses
To investigate baseline perceptions of perceived effectiveness and
intention, we first restricted analysis to subjects who did not view
an advertisement. We used t-tests to assess differences in each
outcome measure between subjects judging lifestyle change and
those judging drugs.
To assess the effect of advertisement exposure, we fit a linear
regression model with normally distributed error terms to predict
each outcome measure (Supplementary Methods, Model 1).
Each model included main effects for advertisement exposure
(subject viewed, versus did not view, an advertisement), type of
health intervention judged (subject judged lifestyle change versus
drugs), health condition (subject judged the outcome measure
for high cholesterol, diabetes, or depression). We were primarily
interested in the interaction of advertisement exposure with type
of health intervention judged, as it estimates a possible differential
effect of advertisement exposure for lifestyle change versus drugs.
For the general effectiveness and personal intention measures,
a negative interaction would indicate that advertisement
exposure disproportionately improved perceptions of drugs
versus lifestyle change. For the disease severity measure, lower
scores indicate greater effectiveness, so a positive interaction
would indicate the same. We also included interactions
accounting for the possibility that some health conditions are
perceived as especially conducive to either lifestyle change or
drugs.
Secondary Analyses
To assess whether individual problem status moderates a
potential boomerang effect of advertisement exposure, we also
analyzed a secondary model including a three-way interaction
term of problem status.
If perceived ineffectiveness is a significant barrier to adopting
a healthy lifestyle, then individuals who do not currently
follow lifestyle recommendations for exercise and diet would be
expected to perceive lifestyle as less effective than individuals
who do follow recommendations. We investigated this possibility
by restricting analysis to only subjects who did not view an
advertisement. Among this subset, we fit a linear regression
model (Supplementary Methods, Model 2) predicting each
outcome measure with type of health intervention judged and
current self-reported lifestyle (the subject meets both exercise and
dietary requirements or does not). The interaction between the
two variables is the term of primary interest, as it represents a
differential effect of intervention type between subjects with high
and low problem status.
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FIGURE 2 | Study flow diagram.
RESULTS
Sample Characteristics
Data quality was excellent. Reported comprehension of all
questionnaire items was very high, with only four subjects
reporting any confusion. Of 850 subjects who finished the
study and who had not previously completed a pilot trial, we
excluded 31 responses (3.6%) due to quality problems (6 reported
technical or comprehension problems, 18 failed the attention
check question, and 7 gave unreasonable body metrics; Figure 2).
Sensitivity analyses that instead included all subjects yielded
nearly identical results. Thus, the final analyzed sample size
was 819; the breakdown by condition is presented in Figure 1.
Negligible differences in sample size across the conditions are due
to dropout.
Subjects were predominantly male (62.0%), young (median
age 27 years), and relatively educated (e.g., 38.2% held a 4-
year college degree). Slightly more than half met national
standards for diet (55.8%) and for exercise (55.6%), and 24.1%
reported regularly taking a prescription drug. Subjects were
on average borderline overweight (median BMI 25.0 kg/m2)
and reported watching a median of 2.0 h of television daily
(Supplementary Table S1). Although we did not collect data
on ethnic characteristics in this study, our recent work using
nearly identical recruitment procedures (Mathur and Reichling,
2016) found the ethnic background of Mechanical Turk users to
be approximately 80% Caucasian, 11% Hispanic, 6% Southeast
Asian, 5% Native American, and <5% each: East Asian, South
Asian, Pacific Islander, Black, and Middle Eastern (percentages
sum to more than 100% due to multiracial subjects).
Baseline Perceptions of Lifestyle Change
and Drug
We assessed baseline perceptions of lifestyle and pharmaceutical
intervention effectiveness among the n = 303 subjects who did
not view a drug advertisement (Table 2), finding that subjects
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TABLE 2 | Perceived effectiveness of lifestyle change versus drugs by advertisement exposure.
General effectiveness p-value Disease severity score p-value Intention to use p-value
Did not watch advertisement
Lifestyle (n = 151) 80.2 (15.1) 106.4 (27.6) 71.8 (22.3)
Drug (n = 152) 62.8 (20.4) <0.001 104.0 (28.4) 0.45 62.5 (32.9) 0.004
Watched advertisement
Lifestyle (n = 257) 77.6 (17.2) 102.8 (29.0) 78.8 (20.8)
Drug (n = 259) 66.3 (18.5) <0.001 104.4 (27.6) 0.52 58.8 (32.4) <0.001
Data reported are means and SDs. n = 819.
considered lifestyle change to be more effective, or as effective,
as drugs for all outcome measures. Specifically, perceived general
effectiveness was much higher for lifestyle than pharmaceutical
interventions (mean VAS units 80.2 and 62.8, p < 0.001).
A similar pattern occurred for personal intention (means 71.8
and 62.5, p = 0.004). However, disease severity score did not
differ significantly between intervention types (means 106.4 and
104.0, p= 0.45).
We also assessed whether baseline perceptions of lifestyle
change and drugs depended on whether subjects themselves
followed lifestyle recommendations for exercise and diet.
Personal adherence to lifestyle recommendations was unrelated
to relative perceived effectiveness of lifestyle change and
drug: Among subjects not exposed to an advertisement, there
was no significant interaction of meeting lifestyle criteria
with intervention type for either the general effectiveness (b
coefficient = 5.44, p-value = 0.20, partial R2 = 0.004) or the
disease severity score measure (b = −6.50, p = 0.32, partial
R2 = 0.003)2.
Boomerang Effects of Advertisement
Exposure
In primary regression analyses (Table 3; Figure 3), the endpoint
of interest was the interaction coefficient of advertisement
exposure with intervention type, which measures the relative
impact of advertisement exposure on perceptions of lifestyle
change versus drugs (the boomerang effect). We found that
advertisement exposure increased perceived general effectiveness
slightly more for drugs versus lifestyle change. However,
the opposite was true for the personal intention measure:
advertisement exposure disproportionately increased personal
intention to use lifestyle versus drugs. That is, there was a small,
but significant, negative interaction for the general effectiveness
outcome (b = −6.2, p = 0.01, partial R2 = 0.007), no significant
interaction for the disease severity score outcome (b = −3.9,
p = 0.32, partial R2 = 0.0009), and a positive interaction for
the personal intention outcome (b = 10.6, p = 0.006, partial
2In this case, the interaction for the personal intention measure would not be
meaningful as it is in the other analyses. Interpretation of this question depends
on whether one currently adheres to lifestyle recommendations: subjects who do
not personally adhere to lifestyle recommendations would interpret the question
as gauging their willingness to change their current lifestyle and those who do
personally adhere to lifestyle recommendations would likely interpret the question
as gauging their willingness to maintain their current lifestyle. (The inherent
dependence of the question interpretation on the subject’s personal adherence to
lifestyle is inconsequential in the other analyses due to randomization.)
R2 = 0.008). Omitting the main effect of health condition
and interactions of health condition with intervention type, or
stratifying on health condition (Supplementary Figure S1), did
not appreciably change results. Including three-way interaction
terms of health condition with intervention type suggested
some significant differences in the interaction of interest across
diseases, but these were not consistent across outcome measures.
Individual Problem Status
To estimate the difference in potential “boomerang” effects
between subjects with high versus low problem status, we fit
three-way interactions of individual problem status (meeting
both dietary and exercise requirements) with advertisement
exposure and intervention type. We found no evidence for
moderation by problem status: the interaction terms were non-
significant for all outcomes (general effectiveness: b = −3.2,
p= 0.54, partial R2 = 0.0004; disease severity: b=−0.4, p= 0.97,
partial R2 < 0.0001; personal intention: b = −14.1, p = 0.07,
partial R2 = 0.0006).
Effect of Television Exposure
Because it appeared counter-intuitive that drug advertisements
would not substantially increase perceived effectiveness or
personal intention to use the advertised products, we performed
post hoc secondary analyses assessing the role of time spent
watching television. If subjects were already saturated by
everyday exposure to DTC advertisements, then the lack of effect
of a single experimental exposure to advertisements might belie a
cumulative shift in perceptions as a result of chronic exposure to
such advertisements.
We conducted two analyses to investigate this possibility.
First, to assess whether subjects with little or no chronic
exposure to DTC television advertisements would be sensitive to
experimental exposure, we repeated analyses among only those
subjects who reported watching no television on a typical day
(n= 163). Advertisement exposure had no significant interaction
with intervention for the general effectiveness (b = −3.2,
p = 0.62, partial R2 = 0.008) or disease severity score measures
(b=−13.2, p= 0.18, partial R2 = 0.007). As in the main analysis,
there was a large positive interaction for the personal intention
measure (b= 19.7, p= 0.02, partial R2 = 0.03).
Additionally, we investigated whether, among subjects who
did not view an advertisement (n = 303), increased television-
watching was associated with a more favorable perception of
drugs versus lifestyle change. We fit a linear regression model
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TABLE 3 | Boomerang effects of advertisement exposure on perceptions of lifestyle and drug effectiveness
Outcome Variable Coefficient (SE) 95% CI p-value
General effectiveness Intervention judged
Drugs Ref Ref Ref
Lifestyle 19.5 (2.6) [14.4, 24.7] <0.001
Ad exposure
No ad Ref Ref Ref
Watched ad 3.6 (1.8) [0.1, 7.0] 0.04
Health condition
Cholesterol Ref Ref Ref
Diabetes 9.2 (2.1) [5.1, 13.2] <0.001
Depression −6.6 (2.1) [−10.7, −2.5] 0.002
Lifestyle ∗ Watched ad −6.2 (2.5) [−11.1, −1.3] 0.01
Lifestyle ∗ Diabetes −6.3 (2.9) [−12.1, −0.6] 0.03
Lifestyle ∗ Depression 0.6 (2.9) [−5.1, 6.4] 0.83
Disease severity score Intervention judged
Drugs Ref Ref Ref
Lifestyle 1.3 (4.1) [−6.8, 9.5] 0.75
Ad exposure
No ad Ref Ref Ref
Watched ad 0.2 (2.8) [−5.24, 5.7] 0.94
Health condition
Cholesterol Ref Ref Ref
Diabetes −10.7 (3.3) [−17.2, −4.3] 0.001
Depression −18.2 (3.3) [−24.7, −11.7] <0.001
Lifestyle ∗ Watched ad −3.9 (4.0) [−11.6, 3.9] 0.32
Lifestyle ∗ Diabetes 3.5 (4.7) [−5.6, 12.7] 0.45
Lifestyle ∗ Depression −0.1 (4.7) [−9.3, 9.0] 0.98
Personal intention Intervention judged
Drugs Ref Ref Ref
Lifestyle 16.3 (4.0) [8.5, 24.1] <0.001
Ad exposure
No ad Ref Ref Ref
Watched ad −3.5 (2.7) [−8.8, 1.8] 0.19
Health condition
Cholesterol Ref Ref Ref
Diabetes 20.8 (3.2) [14.6, 27.0] <0.001
Depression −6.3 (3.2) [−12.5, −0.04] 0.05
Lifestyle ∗ Watched ad 10.6 (3.8) [3.1, 18.0] 0.006
Lifestyle ∗ Diabetes −18.6 (4.5) [−27.4, −9.8] <0.001
Lifestyle ∗ Depression −1.3 (4.5) [−10.1, 7.5] 0.77
Coefficients are presented in visual analog scale (VAS) units. The scales for general effectiveness and intention ranged from 0 to 100, with higher scores indicating higher
effectiveness or intention. The scale for disease severity score ranged from 0 to 180, with lower scores indicating lower disease severity. n = 819.
(Supplementary Methods, Model 3) to predict each outcome
measure with main effects and the interaction of the number
of hours of television watched on a typical day with type of
intervention judged (lifestyle change versus drugs).
A negative interaction between television-watching time and
lifestyle change (versus drugs) would indicate that individuals
watching more television had a relatively less favorable view of
lifestyle (versus drugs) than individuals watching less television.
In fact, there was no such interaction for any of the outcome
measures (general effectiveness: b = −0.9, p = 0.34, partial
R2 = 0.002; disease severity score: b = 0.2, p = 0.89, partial
R2 < 0.0001; personal intention: b = −1.4, p = 0.33, partial
R2 = 0.003). Therefore, regularly consuming more television, and
by proxy more DTC television advertisements, did not appear to
shift perceptions of relative effectiveness or personal intention to
use lifestyle change versus drugs.
Older Subjects
Because our sample was relatively young (median age 27 years),
we performed a sensitivity analysis to assess whether the primary
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FIGURE 3 | Main effects and interaction of intervention type with advertisement exposure. Values are presented in visual analog scale (VAS) units. The
scales for general effectiveness and intention ranged from 0 to 100, with higher scores indicating higher effectiveness or intention. The scale for disease severity
score ranged from 0 to 180, with a starting score of 161 before the intervention and lower scores indicating better health; the vertical axis in the disease severity plot
is reversed for consistency. Error bars represent 95% confidence intervals. n = 819.
endpoint (the interaction of advertisement exposure with health
intervention judged) differed by subject age by introducing a
three-way interaction in analysis models. These coefficients were
small and not statistically significant, suggesting that primary
findings were fairly robust to differences in subject age. Power
may have been limited by low variability in subject age.
DISCUSSION
To our knowledge, this is one of the first randomized experiments
on the effects of real direct-to-consumer television advertisement
exposure on viewers’ relative perceptions of lifestyle change and
drugs to alleviate disease. Past experimental research has mostly
used simple printed advertisements that may not have captured
the complex, often conflicting portrayal of lifestyle change in real
DTC television advertisements. Past observational research may
have been limited by confounding, for example with sociological
factors such as peer effects, whereas our design enables rigorous
causal conclusions. The present study used a high-powered
randomized design to estimate relative judgments of lifestyle
change versus drugs and directly assess possible “boomerang
effects” of DTC advertising exposure. In order to most closely
capture the effect of real-life DTC advertising, stimuli were actual
advertisements previously aired on US national television, and we
did not manipulate advertisement content.
In contrast to previous findings, exposure to DTC
advertisements induced only a weak boomerang effect on
perceived general effectiveness and induced a reverse boomerang
effect of similar magnitude on personal intentions. If subjects
already viewed large numbers of similar advertisements
in everyday life, a single experimental exposure might be
insufficient to shift perceptions. However, we measured
perceptions immediately after advertisement exposure, a method
sensitive to even short-lived effects. Also, advertisement exposure
had little effect among even subjects who watched no television.
In contrast to previous observations that patients with higher
self-reported exposure to advertising were more likely to request
prescription drugs (Mintzes et al., 2003), we found that regular
television consumption was not associated with perceptions
of drug effectiveness, either in absolute terms or relative to
lifestyle. These effects were not moderated by individual problem
status. The discrepancy with previous observational findings
could arise if DTC advertisements influence prescription drug
requests through mechanisms other than perceived effectiveness
and intention – for example, by raising disease awareness or
increasing visits to physicians.
Unexpectedly, we found that advertisement exposure induced
a small “reverse boomerang effect” on personal intentions
to use lifestyle change relative to drugs. We suggest two
possible explanations. First, a key proposed mechanism of
the boomerang effect is that people may tend to associate
prescription drug use with poor health, and this association
may in turn reduce the viewer’s perceived ability to engage in
healthy lifestyle change via reduced self-efficacy (Bolton et al.,
2008). However, as we noted in our introduction, real DTC
television advertisements frequently portray characters engaging
in physically active behaviors not consistent with poor health;
such portrayals may suppress or reverse detrimental effects
on self-efficacy. Second, we speculate that these portrayals
may additionally invoke beneficial descriptive norms regarding
the prevalence of physical activity, convincing the viewer that
“everyone is doing it.” Indeed, norm induction is a potent
method of behavior change in many domains (Rivis and Sheeran,
2003). Although our sample of advertisements was not large
enough to assess whether specific aspects of lifestyle portrayal
moderated individual advertisements’ effects, such analyses of
content would be valuable future directions. Additionally, future
research could begin investigating our proposed mechanisms by
assessing mediation by self-efficacy and descriptive norms.
Our research has limitations. Our sample was not a national
random sample and generalizability is unknown, although as
previously discussed, Mechanical Turk samples tend to more
closely resemble national demographic characteristics than do
traditional university study samples. Health-related lifestyle
behaviors, and hence potentially also perceptions of their
effectiveness, are known to differ by race. Therefore, the baseline
perceptions of our predominantly Caucasian sample may not
generalize to more racially diverse populations (Dong et al.,
2013). We used self-reported measures of perceived effectiveness
and personal intention, which may be subject to demand
characteristics and self-promotion biases. To minimize these
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biases, we used uninformative study descriptions for recruiting
and worded the questionnaire using neutral terms (Lavrakas,
2008). Future research could incorporate behavioral and implicit
attitude measures to supplement the self-report measures used
in our study (Greenwald et al., 1998). Additionally, perceptions
of intervention effectiveness for a given health condition may be
different among disease-affected versus healthy individuals. For
example, the target health conditions may be more familiar or
personally salient to older, at-risk individuals; however, sensitivity
analyses suggested that findings did not differ by age. Because we
were interested in considering boomerang effects in the context
of public health implications of DTC advertising, we did not
restrict sampling to subjects aﬄicted with the diseases of interest.
However, future research could specifically recruit from these
populations.
Framing our work within the broader national debate on
the regulation of DTC advertising, our findings provide a
useful perspective on a specific hypothesized negative effect
of DTC advertisements on viewers. Several other factors
should also be considered in federal decision-making regarding
regulation of DTC advertisements, and indeed regarding
whether these advertisements should be permitted at all. For
example, the potential economic effects of DTC advertising
on prescription drug prices require nuanced assessment.
Pharmaceutical companies’ advertising expenses may trickle
down to the consumer (Gagnon and Lexchin, 2008), potentially
contributing to extremely high costs of medications in the
United States (Tefferi et al., 2015); on the other hand, some
speculate that advertising actually promotes beneficial market
competition between pharmaceutical companies (Wilkes et al.,
2000). Policymakers should ultimately use empirical evidence to
weigh such economic and health-systems impacts as well as their
cognitive impacts on the consumer, including those evaluated in
our study.
CONCLUSION
We find that DTC television advertisements can paradoxically
induce a weak boomerang effect on perceived effectiveness
while also inducing an unexpected “reverse boomerang effect”
with a comparable effect size on personal intentions. Given the
contrast between our findings and those of past experiments
using artificially created print advertisements, we have outlined
possible mechanisms by which the observed reverse boomerang
effect might occur, informed by established theories of descriptive
norm induction and self-efficacy. Future work could therefore
use a large sample of real advertisements to investigate whether
content features predict the extent to which a particular
advertisement does or does not induce boomerang effects.
By elucidating the paradoxical psychological effects of DTC
advertising, such research could ultimately inform evidence-
based policy on DTC advertising regulation.
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